Medical Director @caseccc CRO | Associ Prof | Cleveland Clinic Taussig Cancer Institute | EIC @ASHClinicalNews | Opinions here are mine
Cleveland, OH
Joined December 2014
- Tweets4.4K
- Following1.1K
- Followers3.6K
- Likes6.9K
Pinned Tweet
"Of course, this would be in violation of some rules of time travel – right, Biff?"
Knowing Nothing Has Meant Everything ashpublications.org/ashclini…
Aaron Gerds MD, MS retweeted
#ASH25 In patients with #myelofibrosis, the mutant CALR-specific monoclonal antibody INCA33989 was well tolerated as monotherapy or in combination with #ruxolitinib, with 37% and 30% of patients having SVR25 and SVR35, respectively, at 24 weeks: ow.ly/uk6G50XF6zu
Exciting stuff happening here at the @ASH_hematology Annual Meeting! #mpnsm @ClevelandClinic @CleClinicNews #ASH25
Aaron Gerds MD, MS retweeted
Imaging's Hidden Cost: There may be a link between #medical #imaging and childhood #BloodCancers. A retrospective cohort study found that 10.1% of #hematologic cancers in children may be caused by #radiation exposure from medical imaging.
Stop by our poster on Sunday! Paper No: 4340 Using a medically trained LLM-based end-to-end system in automating patient eligibility screening across a health system for A phase 3 study evaluating the safety of givinostat in patients with PV. #ASH25 @ClevelandClinic
Aaron Gerds MD, MS retweeted
Ahead of #ASH25, @AaronGerds, @n_gangat, and John O. Mascarenhas, MD, weigh in on the most anticipated presentations in #MPN.🩸
Sign up below to read their insights👇& ensure you're up to speed on the data poised to shape practice. 📊 @ASH_hematology
🔐onclive.com/view/all-eyes-ar…
redcrossblood.app.link/blood… my last donation went to Philadelphia and Irvine! Coast-to-coast RBCs!
Aaron Gerds MD, MS retweeted
Positive Results from Prospective, Randomized, Phase 3 Registrational Trial of Pelabresib Ruxolitinib for JAK Inhibitor-Naive Myelofibrosis consultqd.clevelandclinic.or… via @clevelandclinic @AaronGerds @CleClinicMD @ClevelandClinic
Aaron Gerds MD, MS retweeted
Socioeconomic disparities affect access to allogeneic hematopoietic stem cell transplantation for people with acute myeloid leukemia, according to data presented at #ASH24. Healio spoke with @AaronGerds of @caseccc about the findings. #AML #Leukemia
healio.com/news/hematology-o…
Congrats to Dr. Natalie Wuliji of @fredhutch at #ASH24 for a wonderful plenary discussion! This study examined socioeconomic factors of patients undergoing #bmt for #AML. Honored to be a part of it. @ClevelandClinic @MukherzSudipto
Aaron Gerds MD, MS retweeted
#ASH24 Among patients with heavily pretreated, R/R #ChronicLymphocyticLeukemia, treatment with the #bispecific antibody #epcoritamab led to high rates of overall and complete response, as well as a high rate of uMRD: ow.ly/kZ4k50UmYFa
Aaron Gerds MD, MS retweeted
According to findings to be presented at #ASH24, reduced #DOAC dosing was found to be associated with a decreased #bleeding rate and lower #healthcare utilization in the setting of secondary prevention of #VTE: ow.ly/Nx6L50UmzMS
Aaron Gerds MD, MS retweeted
Looking Forward: Advances and Obstacles in Blood Cancer Treatment consultqd.clevelandclinic.or… via @clevelandclinic @AaronGerds @OncoAlert @CarrawayHetty
Excited to have #OncLiveSSOS underway here in the #CLE! @OncLive @AkritiGJain @CloneTracker @CleClinicMD @caseccc
Aaron Gerds MD, MS retweeted
Three generations- dedication, passion for supporting @bikeVeloSano thank you @AaronGerds !! @ClevelandClinic @CleClinicMD !!
